ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

AMRX Amneal Pharmaceuticals Holding Co

5.87
0.00 (0.00%)
May 02 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Amneal Pharmaceuticals Holding Co AMRX NYSE Common Stock
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 5.87 19:00:00
Open Price Low Price High Price Close Price Previous Close
5.87 5.87
more quote information »

Recent News

Date Time Source Heading
5/03/202405:14EDGAR2Form 8-K - Current report
5/03/202405:00BWAmneal Reports First Quarter 2024 Financial Results
4/24/202407:00BWAmneal Announces U.S. FDA Approval of Over-the-Counter..
4/16/202407:00BWAmneal Launches PEMRYDI RTU®, the First Ready-to-Use Version..
4/10/202407:00BWAmneal to Report First Quarter 2024 Results on May 3, 2024
3/28/202415:05BWAmneal to Ring the Nasdaq Closing Bell on April 2, 2024
3/25/202415:05BWAmneal Receives U.S. FDA Approval for Ciprofloxacin and..
3/22/202407:01EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
3/22/202407:01EDGAR2Form DEF 14A - Other definitive proxy statements
3/06/202416:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/06/202416:39EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/05/202415:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
3/01/202405:13EDGAR2Form 8-K - Current report
3/01/202405:00BWAmneal Reports Fourth Quarter and Full Year 2023 Financial..
2/29/202415:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2/27/202407:00BWAmneal Enters into Exclusive European Licensing Agreement..
2/13/202407:00BWAmneal to Participate at Upcoming Investor Conference
2/08/202415:05GLOBEAmneal Announces Complete Response Resubmission for IPX203..
1/31/202415:05BWAmneal to Report Fourth Quarter and Full Year 2023 Results..
1/10/202407:00BWAmneal Launches Complex Generic Fluorometholone Ophthalmic..
1/04/202415:05BWAmneal Launched Record Number of 39 New Retail and..
12/26/202315:10EDGAR2Form 25 - Notification of the removal from listing and..
12/26/202315:05EDGAR2Form 8-A12B - Registration of securities [Section 12(b)]
12/21/202307:00BWAmneal to Participate at the 42nd Annual J.P. Morgan..
12/15/202315:15EDGAR2Form 8-K - Current report
12/15/202315:06EDGAR2Form 8-K/A - Current report: [Amend]
12/15/202315:05BWAmneal Announces Move to Nasdaq
12/07/202307:00BWAmneal and BIAL Announce U.S. Licensing Agreement for..
12/01/202315:15EDGAR2Form SC 13D/A - General statement of acquisition of..
12/01/202315:15EDGAR2Form 4/A - Statement of changes in beneficial ownership of..
12/01/202307:00BWAmneal Expands Portfolio with Addition of Icosapent Ethyl..
11/20/202305:07EDGAR2Form 15-12G - Securities registration termination [Section..
11/08/202317:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202317:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202317:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202317:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/08/202316:15EDGAR2Form S-8 POS - Securities to be offered to employees in..
11/08/202316:13EDGAR2Form POS AM - Post-Effective amendments for registration..
11/08/202316:12EDGAR2Form POS AM - Post-Effective amendments for registration..
11/08/202316:07EDGAR2Form SC 13D/A - General statement of acquisition of..
11/08/202316:05EDGAR2Form SC 13D/A - General statement of acquisition of..
11/08/202316:03EDGAR2Form SC 13D/A - General statement of acquisition of..
11/08/202315:59EDGAR2Form SC 13D/A - General statement of acquisition of..
11/08/202315:55EDGAR2Form SC 13D/A - General statement of acquisition of..
11/08/202306:40EDGAR2Form 8-K12B - Notification that a class of securities of..
11/07/202305:21EDGAR2Form 8-K - Current report
11/07/202305:00BWAmneal Reports Third Quarter 2023 Financial Results
11/03/202307:00BWAmneal to Participate at Upcoming Investor Conferences

Your Recent History

Delayed Upgrade Clock